Clinical Infectious Diseases: Open Access

Scientific advisor, Catalysis SL, Madrid, Spain

Publications

• Review Article   
  Effectiveness of VIUSID^® and ASBRIP^® in Hospitalized Patients Infected by SARS-CoV-2 and Mild-to-Moderate Respiratory Illness. An Observational Prospective Study
  Author(s): Wilson I Benites*, Martha V Heras, Mario L Mero and David Marquez
  
  Background: The emerging SARS-CoV-2 infection has been associated with moderate and severe disease in patients with a weaker cellular immunity which might result in prolonged period of hospitalizations. Viusid® has shown recognized immunoregulator properties, including an important modulation on IFN-δ, TNF-α, IL-1β and IL-6 levels in patients with infectious diseases. Our observational study was aimed to evaluate the effectiveness of Viusid® along with Asbrip®, an upper respiratory antiseptic, in patients with mild to moderate symptoms related with SARS-COV-2 infection. Methods: An observational study was conducted to evaluate the efficacy of Viusid and Asbrip® in patients with mild to moderate symptoms of respiratory disease caused by the emerging SARS-CoV-2 infectio.. Read More»
  DOI: 10.37421/2684-4559.2021.5.145

  Abstract HTML PDF